In this announcement 'ECHOiQ ANNOUNCES MAIDEN CLINICIAL TRIAL SITE FOR ECHOiQ TECHNOLOGY - ST VINCENT’S CLINIC SYDNEY' from October last year it says the following 'Trial commences in October 2021 with anticipated conclusion in Q1 2022'
From the screenshot of the investor presentation above it says 'most approvals in place Sydney'?
Can someone please clarify this for me?
Did I misread the announcements?
Thank you
latest News, page-4
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $96.77M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 17.0¢ | $85.15K | 489.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2380 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 374980 | 5 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| EIQ (ASX) Chart |